TriSalus Life Sciences News and Activities

View the org chart displaying its 18 main executives

Most searched biographies at TriSalus Life Sciences

• Mary Szela, President, Chief Executive Officer and Director
• Mats Wahlstrom, Chairman of the Board
• Kerry Hicks, Director

Popular executive movements at TriSalus Life Sciences

• Richard Marshall who is Medical Director, will be promoted to Chief Medical Officer on Jun. 29, 2026  (posted on May 3 2026).
• Jodi Devlin, Chief of Clinical Strategy and Operations, will retire on Oct. 1, 2026  (posted on April 30 2026).
• Richard Marshall, who was Medical Director, is promoted to Chief Medical Officer  (posted on April 8 2026).

Click here to view some more movements at TriSalus Life Sciences

Create your alert
to follow the executive moves at TriSalus Life Sciences.

TriSalus Life Sciences has 1,235 competitors including Thermo Fisher Scientific (United States (USA)), Medtronic (Ireland) and Philips (Netherlands).

Popular M&A news in Medical Equipment

• Niowave has just announced a $70 Million fundraising (posted on June 2 2026).
• The new name of Edap Tms is FocalTherics. (posted on June 1 2026).
• FocalTherics is now listed under ticker FOCL. (posted on May 31 2026).

Popular contacts in Medical Equipment

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Jacob Thaysen - Chief Executive Officer and Director at Illumina
• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet

Learn more about the Medical Equipment industry

Press releases by TriSalus Life Sciences

• TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences to Participate in Upcoming Investor Conferences | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025 | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences to Participate in Upcoming September Investor Conferences | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance | TriSalus Life Sciences, Inc.
• TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique | TriSalus Life Sciences, Inc.
• View more press releases Close

Social media about TriSalus Life Sciences

• TriSalus Life Sciences on Wikipedia, Google News & Yahoo Finance
• TriSalus Life Sciences on LinkedIn, X (Twitter) & YouTube